Return to homepagePandemic Pact

Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patiENts (RAVEN)

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    LifeArc

  • Principal Investigator

    Unspecified Unspecified Unspecified

  • Research Location

    United Kingdom

  • Lead Research Institution

    King?s College London and Guy?s and St Thomas?

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The team will collaborate on the biomarker analysis with Dr Steven Chan's team at the University of Toronto, University Health Network who are also conducting a trial with ruxolitinib.